Neurodevelopmental and growth outcomes of extremely preterm infants with necrotizing enterocolitis or spontaneous intestinal perforation.


Journal

Journal of pediatric surgery
ISSN: 1531-5037
Titre abrégé: J Pediatr Surg
Pays: United States
ID NLM: 0052631

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 02 03 2020
revised: 24 04 2020
accepted: 09 05 2020
pubmed: 20 6 2020
medline: 25 6 2021
entrez: 20 6 2020
Statut: ppublish

Résumé

To evaluate neurodevelopment and growth in extremely preterm infants with or without necrotizing enterocolitis or spontaneous intestinal perforation. We conducted a retrospective cohort study of infants admitted to Canadian neonatal intensive care units in 2010 to 2011. We assessed outcomes at 18 to 24 months' corrected ages for preterm infants <29 weeks of gestational age at birth with spontaneous intestinal perforation or non-perforated or perforated necrotizing enterocolitis, and for preterm infants with none of these gastrointestinal complications. The primary outcome was a composite of death or significant neurodevelopmental impairment at 18 to 24 months' corrected age. We used multivariable logistic regression models to adjust for gestational age, small for gestational age, prenatal steroids, cesarean section, multiple gestations, and SNAP-II score. Of 2,019 infants total, 39 (1.9%) had spontaneous intestinal perforation, 61 (3%) had perforated necrotizing enterocolitis, and 115 (5.7%) had non-perforated necrotizing enterocolitis. Infants with spontaneous intestinal perforation (aOR 2.11; 95% CI 1.01-4.42), necrotizing enterocolitis (aOR 2.58; 95% CI 1.81-3.68), or any bowel perforation (aOR 3.97; CI 2.43-6.48) had higher odds of death or significant neurodevelopmental impairment compared to infants with none of these bowel diseases. Spontaneous intestinal perforation, necrotizing enterocolitis, or any bowel perforation are risk factors for death or significant neurodevelopmental impairment in extremely preterm infants. Study type: prognosis study (cohort study: retrospective) LEVEL OF EVIDENCE RATING: II.

Identifiants

pubmed: 32553453
pii: S0022-3468(20)30326-2
doi: 10.1016/j.jpedsurg.2020.05.013
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

309-316

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Carlos Zozaya (C)

Department of Pediatrics, Mount Sinai Hospital, Toronto, Ontario, Canada.

Jyotsna Shah (J)

Department of Pediatrics, Mount Sinai Hospital, Toronto, Ontario, Canada.

Agostino Pierro (A)

Division of General and Thoracic Surgery, The Hospital for Sick Children, Toronto, Ontario, Canada.

Augusto Zani (A)

Division of General and Thoracic Surgery, The Hospital for Sick Children, Toronto, Ontario, Canada.

Anne Synnes (A)

Department of Pediatrics, British Columbia's Women's Hospital and Health Centre, Vancouver, British Columbia, Canada.

Shoo Lee (S)

Department of Pediatrics, Mount Sinai Hospital, Toronto, Ontario, Canada.

Prakesh S Shah (PS)

Department of Pediatrics, Mount Sinai Hospital, Toronto, Ontario, Canada. Electronic address: Prakeshkumar.shah@sinaihealthsystem.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH